Reported 1 day ago
UnitedHealth Group and Amedisys have agreed to extend their timeline for completing a $3.3 billion acquisition deal, which faces scrutiny from the government. The companies have waived their right to terminate the agreement if not completed by certain dates, pending a court ruling on the Justice Department's antitrust lawsuit, which argues the merger could reduce competition in home-health services. Despite an increase in Amedisys's shares, regulators remain concerned about the implications of the deal.
Source: YAHOO